BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
76.80
-0.56 (-0.72%)
At close: Nov 17, 2026, 4:00 PM EST
76.76
-0.04 (-0.05%)
After-hours: Nov 17, 2026, 5:52 PM EST
BridgeBio Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,533 | 570.12 | 681.1 | 375.94 | 376.69 | 393.77 |
Short-Term Investments | 5.49 | 17.36 | - | 58.95 | 95.23 | 442.89 |
Cash & Short-Term Investments | 1,539 | 587.48 | 681.1 | 434.88 | 471.92 | 836.66 |
Cash Growth | 138.23% | -13.74% | 56.62% | -7.85% | -43.59% | 37.81% |
Accounts Receivable | 375.09 | 139.44 | 4.72 | 1.75 | 17.08 | 19.75 |
Receivables | 375.09 | 139.44 | 4.72 | 1.75 | 17.08 | 19.75 |
Inventory | 59.72 | 26.75 | - | - | - | - |
Prepaid Expenses | 69.39 | 38.42 | 31.04 | 24.31 | 21.92 | 32.27 |
Restricted Cash | 0.55 | 0.55 | 0.13 | 16.65 | 37.93 | 0.18 |
Other Current Assets | 1 | 5.1 | 3.7 | - | - | - |
Total Current Assets | 2,045 | 797.75 | 720.69 | 477.59 | 548.85 | 888.86 |
Property, Plant & Equipment | 20.79 | 13.52 | 12.78 | 19.84 | 25.25 | 45.97 |
Long-Term Investments | 47.78 | 79.97 | 143.75 | 1.6 | - | - |
Other Intangible Assets | 25.92 | 28.08 | 23.93 | 26.32 | 28.71 | 44.93 |
Other Long-Term Assets | 22.69 | 16.71 | 18.2 | 21.03 | 20.22 | 33.03 |
Total Assets | 2,162 | 936.03 | 919.34 | 546.38 | 623.04 | 1,013 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 88.26 | 36.23 | 9.62 | 10.66 | 11.56 | 11.88 |
Accrued Expenses | 320.14 | 238.36 | 124.08 | 116.97 | 95.54 | 116.75 |
Current Portion of Long-Term Debt | 548.43 | - | - | - | - | - |
Current Portion of Leases | 1.99 | 6.19 | 4.51 | 4.13 | 3.68 | 4.94 |
Current Unearned Revenue | 4.74 | 7.19 | 14.6 | 6.1 | 8.16 | - |
Other Current Liabilities | 13.68 | - | 1.6 | 6 | 2.5 | 1.5 |
Total Current Liabilities | 977.24 | 287.97 | 154.4 | 143.84 | 121.43 | 135.07 |
Long-Term Debt | 2,813 | 1,852 | 1,721 | 1,727 | 1,708 | 1,704 |
Long-Term Leases | 14.65 | 3.81 | 4.7 | 8.98 | 12.27 | 17.43 |
Long-Term Unearned Revenue | 8.97 | 13.08 | 17.1 | 3.73 | 7.1 | - |
Other Long-Term Liabilities | 1.41 | 855.27 | 479.38 | 5.63 | 19.54 | 22.07 |
Total Liabilities | 3,815 | 3,013 | 2,377 | 1,889 | 1,868 | 1,878 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.21 | 0.2 | 0.2 | 0.18 | 0.16 | 0.15 |
Additional Paid-In Capital | 2,170 | 2,058 | 1,903 | 1,481 | 938.7 | 841.53 |
Retained Earnings | -4,194 | -3,821 | -3,096 | -2,561 | -1,918 | -1,437 |
Treasury Stock | -580.78 | -323.28 | -275 | -275 | -275 | -275 |
Comprehensive Income & Other | -0.1 | 0.01 | 0.01 | 0.03 | -0.33 | -0.13 |
Total Common Equity | -2,605 | -2,087 | -1,468 | -1,354 | -1,255 | -870.41 |
Minority Interest | 8.84 | 10.03 | 10.29 | 11.72 | 9.69 | 4.84 |
Shareholders' Equity | -1,654 | -2,077 | -1,458 | -1,343 | -1,245 | -865.58 |
Total Liabilities & Equity | 2,162 | 936.03 | 919.34 | 546.38 | 623.04 | 1,013 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3,378 | 1,862 | 1,731 | 1,740 | 1,724 | 1,726 |
Net Cash (Debt) | -1,839 | -1,275 | -1,049 | -1,305 | -1,252 | -889.51 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -9.43 | -6.66 | -5.64 | -8.02 | -8.49 | -6.16 |
Filing Date Shares Outstanding | 194.8 | 193.86 | 190.19 | 175.83 | 151.37 | 147.61 |
Total Common Shares Outstanding | 196 | 194.77 | 190.04 | 175.08 | 150.63 | 147.34 |
Working Capital | 1,067 | 509.78 | 566.29 | 333.75 | 427.43 | 753.79 |
Book Value Per Share | -13.29 | -10.71 | -7.72 | -7.73 | -8.33 | -5.91 |
Tangible Book Value | -2,631 | -2,115 | -1,492 | -1,381 | -1,283 | -915.35 |
Tangible Book Value Per Share | -13.42 | -10.86 | -7.85 | -7.89 | -8.52 | -6.21 |